Phio Pharmaceuticals Corp.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | $8.2M | $10.2M |
| Jun 2017 | — | $5.9M | $7.7M |
| Sep 2017 | — | $3.4M | $5.4M |
| Dec 2017 | — | $1.8M | $3.6M |
| Mar 2018 | — | $567.0K | $2.6M |
| Jun 2018 | — | $3.3M | $5.3M |
| Sep 2018 | — | $1.8M | $3.2M |
| Dec 2018 | — | $13.6M | $14.9M |
| Mar 2019 | — | $11.7M | $12.8M |
| Jun 2019 | — | $9.7M | $10.9M |
| Sep 2019 | — | $7.6M | $8.8M |
| Dec 2019 | $0 | $5.7M | $7.0M |
| Mar 2020 | — | $12.0M | $13.3M |
| Jun 2020 | $231.0K | $17.7M | $18.9M |
| Sep 2020 | $231.0K | $15.5M | $16.9M |
| Dec 2020 | $231.0K | $13.0M | $14.3M |
| Mar 2021 | $0 | $31.4M | $32.7M |
| Jun 2021 | $0 | $28.8M | $29.5M |
| Sep 2021 | $0 | $25.2M | $26.6M |
| Dec 2021 | $0 | $21.9M | $24.1M |
| Mar 2022 | — | $19.5M | $20.5M |
| Jun 2022 | — | $17.0M | $18.1M |
| Sep 2022 | — | $13.5M | $14.5M |
| Dec 2022 | — | $10.8M | $11.8M |
| Mar 2023 | — | $7.3M | $9.1M |
| Jun 2023 | — | $9.9M | $11.3M |
| Sep 2023 | — | $7.2M | $8.4M |
| Dec 2023 | — | $7.7M | $8.5M |
| Mar 2024 | — | $5.6M | $6.5M |
| Jun 2024 | — | $3.8M | $4.7M |
| Sep 2024 | — | $4.9M | $5.4M |
| Dec 2024 | — | $4.7M | $5.4M |
| Mar 2025 | — | $12.2M | $13.3M |
| Jun 2025 | — | $10.1M | $10.8M |
| Sep 2025 | — | $9.8M | $10.7M |
| Dec 2025 | — | $20.1M | $21.0M |
| Mar 2026 | — | $16.5M | $17.0M |
| Jun 2026 | — | $12.6M | $13.0M |